Skip to main content
Clinical Trials/ISRCTN82233115
ISRCTN82233115
Active, not recruiting
未知

SupPoRtive Exercise Programmes for Accelerating REcovery after major ABdominal Cancer surgery (PREPARE-ABC) – A multicentre, 3 arm, parallel randomised controlled trial of standard care alone versus standard care plus supervised hospital based exercise and standard care plus supported home-based exercise pre and post hospital discharge in cancer patients awaiting curative colorectal cancer surgery

orfolk and Norwich University Hospitals NHS Foundation Trust0 sites1,146 target enrollmentJuly 7, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
Colorectal cancer
Sponsor
orfolk and Norwich University Hospitals NHS Foundation Trust
Enrollment
1146
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/34245094 (added 01/11/2021)

Registry
who.int
Start Date
July 7, 2016
End Date
April 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Male and female participants \= 18 years old
  • 2\. Awaiting a curative elective colorectal resection for cancer
  • 3\. American Society of Anaesthesiologists physical status I\-III (ASA, 2014\)
  • 4\. Able and willing to provide informed consent
  • 5\. Understand verbal and written instructions in English
  • 6\. Patients who are already participating (or have participated) in other trials may be eligible, but this must be agreed in advance by the relevant trial teams

Exclusion Criteria

  • 1\. Contra\-indications to exercise (e.g. lower limb amputation without prosthesis, orthopaedic disorder exacerbated by exercise, chronic lung disease causing desaturation with exercise or shortness of breath at rest, severe psychiatric health problems)
  • 2\. Cardiovascular contraindications (e.g. unstable angina, acute left ventricular failure, uncontrolled cardiac arrhythmias, uncontrolled hypertension, cardiac event in the previous 6 weeks, cerebral vascular disease resulting in transient ischaemic attacks)
  • 3\. Participation in other treatment trials, where this has not been agreed in advance with both trial teams

Outcomes

Primary Outcomes

Not specified

Similar Trials